Healthcare -
Biotechnology - NASDAQ - CH
$ 41.63
1.37 %
$ 3.6 B
Market Cap
-8.59
P/E
CRSP - OPERATING INCOME
Operating Income CRSP - CRISPR Therapeutics AG
-467 M
LAST VALUE
16.75%
2 YEAR CAGR
-61.49%
5 YEAR CAGR
-53.02%
10 YEAR CAGR